Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4

Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert
Drug Metabolism and Disposition September 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985
Kishore K. Khan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
You Qun He
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Almira Correia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James R. Halpert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 30 no. 9 985-990
DOI 
https://doi.org/10.1124/dmd.30.9.985
PubMed 
12167563

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received April 12, 2002
  • Accepted June 3, 2002
  • Published online September 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Kishore K. Khan1,
  2. You Qun He1,
  3. Maria Almira Correia2 and
  4. James R. Halpert1
  1. 1Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas (K.K.K., Y.Q.H., J.R.H.); 2Department of Cellular and Molecular Pharmacology, Department of Pharmaceutical Chemistry, Department of Biopharmaceutical Sciences, and the Liver Center, University of California, San Francisco, California (M.A.C.)
  1. Corresponding author: Kishore K. Khan, Ph.D., Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Route 1031, 301 University Boulevard, Galveston, Texas 77555-1031. E-mail: kkkhan{at}utmb.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 201702310
Sep 201703122
Oct 201733514
Nov 201712814
Dec 20171197
Jan 20180124
Feb 20182166
Mar 201831818
Apr 201811414
May 201842219
Jun 201871918
Jul 20181121
Aug 20181137
Sep 20180106
Oct 20181153
Nov 20180675
Dec 201829133
Jan 20194120
Feb 20196737
Mar 20192910
Apr 20191510
May 20191911
Jun 2019611
Jul 20191003
Aug 2019611
Oct 2019600
Nov 20191911
Dec 20192062
Jan 20201100
Feb 20201511
Mar 20201030
May 2020921
Jun 20201100
Jul 2020800
Aug 2020702
Sep 2020801
Oct 20201010
Nov 2020710
Dec 2020532
Jan 202115142
Feb 202114171
Mar 20211121
Apr 2021621
May 20212730
Jun 20211372
Jul 2021740
Aug 20211060
Sep 2021930
Oct 20211231
Nov 20211410
Dec 20213241
Jan 20221322
Feb 2022711
Mar 2022321
Apr 20221662
May 2022542
Jun 20221920
Jul 2022764
Aug 20221030
Sep 20221210
Oct 202214120
Nov 20221411
Dec 2022510
Jan 20233210

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 30 (9)
Drug Metabolism and Disposition
Vol. 30, Issue 9
1 Sep 2002
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4

Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert
Drug Metabolism and Disposition September 1, 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Differential Oxidation of Mifepristone by Cytochromes P450 3A4 and 3A5: Selective Inactivation of P450 3A4

Kishore K. Khan, You Qun He, Maria Almira Correia and James R. Halpert
Drug Metabolism and Disposition September 1, 2002, 30 (9) 985-990; DOI: https://doi.org/10.1124/dmd.30.9.985
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of payload-containing catabolites of ADCs
  • PK Interactions of Licorice with Cytochrome P450s
  • Biotransformation of Trastuzumab and Pertuzumab
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics